NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Therapeutic Writing for Adults Suffering From Chronic Pain and Comorbid Mental Health Disorders
Therapeutic Writing for Adults Suffering From Chronic Pain and Comorbid Mental Health Disorders

NCT07058532

WithdrawnNA

Sponsor: Toni Salikka

Conditions: Chronic Pain, Mental Health Disorder, Psychiatric &Amp;Amp;or Mood Disorder, Psychiatric Comorbidities, Psychiatric Diagnosis

Interventions: Therapeutic Writing Intervention in Pain Rehabilitation

Countries: Finland

The goal of this observational study is to understand the effects and experiences of therapeutic writing interventions in adult women with chronic pain and co-occurring mental health conditions. The main questions it aims to answer are: Can therapeutic writing help relieve chronic pain and emotional distress? How does writing support emotional processing, regulation, and meaning-making during rehabilitation? Participants will take part in a two-part writing intervention involving: Guided writing exercises that focus on emotional processing, emotion regulation, and creating meaning. Individual interviews after the writing sessions to explore their experiences. The study uses qualitative analysis methods-phenomenology and logotherapy-to better understand how these writing interventions may support recovery, improve well-being, and offer non-pharmacological tools for managing chronic pain and mental health challenges.

Eligibility overview

Sex: FEMALE

Age: 18 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Adult women (18 years or older), assigned female at birth and self-identify as women
* Diagnosed with or experience of chronic, widespread (non-cancer) pain lasting at least two years
* Diagnosed with or living with one or more mild mental health disorders (e.g., anxiety, mild depression), without current or past severe psychiatric conditions
* Diagnosed with or experience of nociplastic pain (e.g., fibromyalgia)
* Not currently using medications that may impair cognitive functioning (e.g., benzodiazepines, anticholinergics, opioids, antipsychotics)
* Able to attend approximately 11 in-person visits over a 3-month period
* Willing and able to participate in a structured therapeutic writing intervention
* Purposefully selected to reflect a range of lived experiences relevant to the study's aims

Exclusion Criteria:

* Presence of severe mental health disorders (e.g., schizophrenia, bipolar disorder, severe depression, or other psychotic conditions)
* Use of medications known to impair memory, attention, or decision-making (e.g., benzodiazepines, anticholinergics, opioids, antipsychotics)
* Participation in other concurrent treatments that may influence study outcomes
* Cognitive limitations that would hinder meaningful engagement in the writing intervention
* Individuals not assigned female at birth or who do not identify as women
Locations (1)
  • Pori, Satakunta, Finland